Could a smoking cessation drug help Parkinson's patients stop falling?
NCT ID NCT06679374
Summary
This study is testing whether a medication called varenicline, taken for one year, can help reduce the risk of falls and improve the ability to walk while doing another task (like talking) in people with Parkinson's disease who also have mild memory problems. About 102 participants will be randomly assigned to receive either the real medication or a placebo pill. The main goal is to see if the drug helps people walk more safely and fall less over the course of a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.